POLYMORPHISMS OF α1-ANTITRYPSIN AND INTERLEUKIN-6 GENES AND THE PROGRESSION OF HEPATIC CIRRHOSIS IN PATIENTS WITH A HEPATITIS C VIRUS INFECTION
Motawi T, Shaker OG, Hussein RM, Houssen M
*Corresponding Author: Rasha M. Hussein, Ph.D., Department of Biochemistry, Faculty of Pharmacy, Beni-Suef University, Salah Salem Street, 62511, Beni-Suef, Egypt. Tel: +20-12-0013-6515. Fax: +20-82-2317-958. E-mail: rasha.hussein@ pharm.bsu.edu.eg
page: 35

REFERENCES

1. Breban R, Doss W, Esmat G, Elsayed M, Hellard M, Ayscue P, et al. Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat. 2013; 20(4): 294-296. 2. Zucker S. Whomsoever ignores the natural history of the hepatitis C virus is doomed to treat it. Gastroenterology. 2002; 122(2): 578-579. 3. Missiha SB, Ostrowski M, Heathcote EJ. Disease progression in chronic hepatitis C: Modifiable and nonmodifiable factors. Gastroenterology. 2008; 134(6): 1699-1714. 4. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009; 461(7262): 399-401. 5. Cussigh A, Falleti E, Fabris C, Bitetto D, Cmet S, Fontanini E, et al. Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. Immunogenetics. 2011; 63(1): 33-41. 6. Giannitrapani L, Soresi M, Giacalone A, Campagna ME, Marasà M, Cervello M, et al. IL-6−174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. OMICS. 2011; 15(3): 183-186. 7. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel poly-morphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998; 102(7): 1369-1376. 8. Falleti E, Fabris C, Vandelli C, Colletta C, Cussigh A, Smirne C, et al. Genetic polymorphisms of interleukin- 6 modulate fibrosis progression in mild chronic hepatitis C. Hum Immunol. 2010; 71(10): 999-1004. 9. Crystal RG, Brantly ML, Hubbard RC, Curiel DT, Holmes MD. The α1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. Chest. 1989; 95(1): 196-208. 10. Norman MR, Mowat AP, Hutchison D. Molecular basis, clinical consequences and diagnosis of α-1 anti-trypsin deficiency. Ann Clin Biochem. 1997; 34(Pt 3): 230-246. 11. Canva V, Piotte S, Aubert J-P, Porchet N, Lecomte- Houcke M, Huet G, et al. Heterozygous M3Mmalton α1-antitrypsin deficiency associated with end-stage liver disease: Case report and review. Clin Chem. 2001; 47(8): 1490-1496. 12. Luisetti M, Seersholm N. α1-Antitrypsin deficiency 1: Epidemiology of α1-antitrypsin deficiency. Thorax. 2004; 59(2): 164-169. 13. Fregonese L, Stolk J. Hereditary α1-antitrypsin deficiency and its clinical consequences. Orphanet J Rare Dis. 2008; 3: 16. doi: 10.1186/1750-1172-3-16. 14. Perlmutter DH, May LT, Sehgal PB. Interferon beta 2/interleukin 6 modulates synthesis of α1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J Clin Invest. 1989; 84(1): 138-144 15. Child CG, Turcotte J. Surgery and portal hypertension. Major Probl Clin Surg. 1964; 1: 1-85. 16. Pugh R, Murray Lyon I, Dawson J, Pietroni M, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8): 646-649. 17. Henry R, Chiamori M, Golub O, Berkman S. Revised spectrophotometric methods for the determination of glutamate oxaloacetic transaminase, glutamic pyruvate transaminase and lactic acid dehydrogenase. Am J Clin Pathol. 1960; 34: 381-387. 18. Amador E, Wacker WE. Serum glutamic-oxaloacetic transaminase activity. A new modification and an analytical assessment of current assay technics. Clin Chem. 1962; 8(4): 343-350. 19. Bretaudiere J, Vassault A, Amsellem L, Pourci M, Thieu-Phung H, Bailly M. Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum. Clin Chem. 1977; 23(12): 2263-2274. 20. Landis JB, Pardue HL. Kinetics of the reactions of unconjugated and conjugated bilirubins with p-diazobenzenesulfonic acid. Clin Chem. 1978; 24(10): 1690-1699. 21. Hirai H. Alpha fetoprotein. In: Chu TM, Ed. Biochemical Markers for Cancer. New York, NY, USA: Marcel Dekker Inc. 1982: 23-59. 22. Glasel J. Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. Biotechniques. 1995; 18(1): 62-63. 23. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: A systematic review and data synthesis. BMC Infect Dis. 2013; 13(1): 288. 24. Guerra J, Garenne M, Mohamed M, Fontanet A. HCV burden of infection in Egypt: Results from a nationwide survey. J Viral Hepat. 2012; 19(8): 560-567. 25. Meenagh A, Williams F, Ross OA, Patterson C, Gorodezky C, Hammond M, et al. Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. Hum Immunol. 2002; 63(11): 1055-1061. 26. Barrett S, Collins M, Kenny C, Ryan E, Keane C, Crowe J. Polymorphisms in tumour necrosis factor α, transforming growth factor β, interleukin 10, interleukin 6, interferon γ, and outcome of hepatitis C virus infection. J Med Virol. 2003; 71(2): 212-218. 27. Pereira FA, Silva NNPd, Rodart IF, Carmo TMAd, Lemaire DC, Reis MGd. Association of TGF-beta1 codon 25 (G915C) polymorphism with hepatitis C virus infection. J Med Virol. 2008; 80(1): 58-64. 28. Jin X, Zimmers TA, Perez EA, Pierce RH, Zhang Z, Koniaris LG. Paradoxical effects of short and long term interleukin 6 exposure on liver injury and repair. Hepatology. 2006; 43(3): 474-484. 29. Shaker OG, Sadik NA. Polymorphisms in interleukin 10 and interleukin 28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin therapy. J Gastroenterol Hepatol. 2012; 27(12): 1842-1849. 30. Shalaby SM, Radwan MI, Abdelazim S, Nafee AM. Interleukin-4 polymorphisms and response to combination therapy in Egyptian chronic hepatitis C patients. Cell Immunol. 2012; 276(1): 110-113. 31. Abdel-Hady H, El-Naggar M, El-Nady G, Badr R, El-Daker M. Genetic polymorphisms of IL-6-174 and IL-10-1082 in full term neonates with late onset blood stream infections. J Pediatr Infect Dis. 2009; 4(4): 357-365. 32. Helaly MA-H, Hatata E-SZ, Abu-Elmagd M, Ibrahem EF, Alsaid A, El-Aal IAA, et al. Association of IL-10 and IL-6 gene polymorphisms with type 2 diabetes mellitus among Egyptian patients. Eur J Gen Med. 2013; 10(3): 158-162. 33. Zekri A, Ashour MS, Hassan A, HM AE-D, El-Shehaby A, Abu-Shady MA. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression. World J Gastroenterol. 2005; 11(42): 6624-6630. 34. Settin A, El-Bendary M, Abo-Al-Kassem R, El Baz R. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis. J Gastrointestin Liver Dis. 2006; 15(2): 131-135 35. Gharib AF, Karam RA, Pasha HF, Radwan MI, Elsawy WH. Polymorphisms of hemochromatosis, and α-1 antitrypsin genes in Egyptian HCV patients with and without hepatocellular carcinoma. Gene. 2011; 489(2): 98-102. 36. de Serres FJ, Blanco I. Prevalence of α1-antitrypsin deficiency alleles PI* S and PI* Z worldwide and effective screening for each of the five phenotypic classes PI* MS, PI* MZ, PI* SS, PI* SZ, and PI* ZZ: a comprehensive review. Ther Adv Respir Dis. 2012; 6(5): 277-295.



Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006